Home / Recalls / AbbVie Inc. / D-0088-2024

D-0088-2024 Class III Ongoing

Recalled by AbbVie Inc. — North Chicago, IL

Recall Details

Product Type
Drugs
Report Date
November 15, 2023
Initiation Date
October 17, 2023
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
864 cartons

Product Description

Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11

Reason for Recall

Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.

Distribution Pattern

Distributed in the US. No government or foreign consignees.

Code Information

Lot # 1187435 exp date: 02/2024

Other recalls by AbbVie Inc.

  • D-0665-2024 Class II — Refresh LACRI-LUBE, (42.5% Mineral Oil, 57.3% White Petrolatum) Lubricant Eye Oi (September 16, 2024)
  • D-0664-2024 Class II — Refresh P.M., (Mineral Oil 42.5%, White Petrolatum 57.3%) Lubricant Eye Ointment (September 16, 2024)
  • D-0412-2018 Class III — Ultane (sevoflurane), 250 mL, Inhalation Anesthetic, Rx only, Manufactured by: (January 22, 2018)
  • D-0034-2018 Class III — AndroGel (testosterone gel) 1.62%, 40.5mg in 2.5g aluminum foil packet, 30 Packe (September 8, 2017)
  • D-0033-2018 Class III — AndroGel (testosterone gel) 1.62%, 88 gm metered-dose pump, 20.25 mg of testoste (September 8, 2017)
  • Z-2177-2017 Class II — AbbVie PEG, PEG Kit 15FR, FOR ENTERAL USE ONLY, STERILE, Rx Only. (April 27, 2017)
  • Z-2176-2017 Class II — AbbVie PEG, PEG Kit 20FR, FOR ENTERAL USE ONLY, STERILE, Rx Only. (April 27, 2017)
  • Z-2178-2017 Class II — AbbVie PEG, PEG Kit 15FR, FOR ENTERAL USE ONLY, STERILE, Rx Only. (April 27, 2017)
  • D-0495-2017 Class II — Duopa (carbidopa and levodopa enteral suspension), 4.63 mg/20 mg per mL, 100 mL (January 13, 2017)
  • Z-0786-2017 Class II — AbbVie PEG Kit 20 FR (November 22, 2016)